Ironwood Pharmaceuticals, Inc.
IRWD
$0.57
-$0.0244-4.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -798.27% | 307.54% | -76.20% | 99.92% | -109.10% |
| Total Depreciation and Amortization | -6.63% | -5.27% | 78.90% | -60.74% | 79.37% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.03% | 2.52% | -25.32% | -97.89% | -37.17% |
| Change in Net Operating Assets | 50.83% | -293.35% | -124.04% | -23.78% | 245.64% |
| Cash from Operations | -55.64% | -57.54% | -69.55% | -4.28% | -43.89% |
| Capital Expenditure | 54.41% | 100.00% | 67.35% | -- | -423.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 54.41% | 100.00% | 99.93% | 99.99% | -423.08% |
| Total Debt Issued | -- | -- | -- | -62.50% | -- |
| Total Debt Repaid | -- | 40.00% | 66.67% | -- | -- |
| Issuance of Common Stock | -99.94% | -79.66% | -100.00% | -45.17% | 152.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 99.67% | -- | -- | -- |
| Cash from Financing | 100.04% | 70.75% | 63.79% | -112.37% | -490.73% |
| Foreign Exchange rate Adjustments | -129.17% | 142.00% | -766.67% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.21% | 101.80% | 73.43% | 97.17% | -65.07% |